Nuclear fuel supplier Centrus Energy (NYSE: LEU) missed Wall Street’s revenue expectations in Q3 2026, with sales falling 25.9% year on year to $55.5 million. Its non-GAAP loss of $0.46 per share was significantly below analysts’ consensus estimates.

Is now the time to buy LEU? Find out in our full research report (it’s free for active Edge members).

StockStory’s take

Centrus Energy’s third quarter performance was met with a negative market response as the company missed Wall Street’s revenue and non-GAAP earnings expectations. Management attributed the shortfall to a shift in contractual mix, lower volumes in its Low Enriched Uranium (LEU) and Technical Solutions segments, and increased costs tied to advanced technology investments. CEO Amir Vexler acknowledged the impact of these factors, noting, “Our normalized results reflected the typical quarter-over-quarter shift in contractual mix that can transpire based on customer orders and deliveries.” The company also highlighted that progress in manufacturing and supply chain initiatives was achieved ahead of schedule, but these advancements came alongside a widening operating loss.

Looking forward, Centrus Energy’s guidance is shaped by ongoing expansion in its enrichment capacity, strategic supply chain integration, and a growing backlog of sales commitments. Management emphasized the company’s unique positioning to address commercial, national security, and advanced nuclear reactor markets, underpinned by recent operational milestones such as the first centrifuge rollout and the Westerman acquisition. CFO Todd Tinelli reiterated the focus on capital deployment and efficiency, stating, “We believe we are sufficiently funded to meet our near-term capital requirements.” Centrus aims to sustain momentum through workforce expansion, new contract wins, and by leveraging its strengthened supply chain and manufacturing capabilities.

Key insights from management’s remarks

Management pointed to advances in manufacturing, supply chain risk reduction, and backlog growth as key developments in the quarter, while addressing persistent margin pressures from shifting contract mix and increased technology investments.

• Operational milestone: centrifuge rollout: Centrus completed its first centrifuge at Oak Ridge ahead of schedule, marking the launch of a new U.S.-based manufacturing line. Management views this as foundational for scaling production and supporting domestic enrichment goals.
• Strategic acquisition of Westerman: The purchase of Westerman, a critical supplier, was highlighted as a move to de-risk the supply chain and achieve cost savings. The transaction provides Centrus with vertical integration benefits and potential revenue diversification through exposure to non-nuclear markets.
• Backlog expansion: The company’s enrichment backlog increased from $3 billion to $5.4 billion in contingent sales commitments, driven by new agreements with customers in both traditional and advanced nuclear sectors. Prepayments from these contracts are expected to fund future buildouts and reinforce Centrus’ market position.
• HALEU and advanced reactor progress: Centrus began using its 16-centrifuge cascade to enrich High-Assay Low-Enriched Uranium (HALEU) for the commercial market, making it the first U.S.-owned commercial supplier in decades. This development supports next-generation reactor projects and validates Centrus’ first-mover advantage in this emerging segment.
• Capital raise and balance sheet: The company secured $500 million from a public offering and ended the quarter with $2.2 billion in unrestricted cash. Management sees this liquidity as critical for funding expansion and maintaining flexibility to address operational needs.

Drivers of future performance

Centrus Energy’s outlook centers on expanding enrichment capacity, leveraging supply chain integration, and capturing demand across commercial and national security markets.

• Capacity ramp and workforce expansion: The company is focused on scaling its centrifuge manufacturing and expanding its operational workforce, especially at Oak Ridge and Piketon. Management expects these efforts to support revenue growth and meet rising demand from both utility and government contracts.
• Advanced reactor and HALEU market opportunities: Centrus is positioning itself to serve the growing market for advanced reactor fuel, including HALEU, while maintaining its core LEU business. The company aims to capitalize on its early entry and flexible production capabilities as new reactor projects move forward.
• Execution risks and contract mix: Management acknowledged timing risks related to customer orders, delivery schedules, and the evolving mix between established LEU customers and new HALEU demand. Fluctuations in contract timing and continued investment in technology and supply chain integration may contribute to ongoing margin volatility.

Catalysts in upcoming quarters

In the coming quarters, the StockStory team will be tracking (1) the cadence and scale of centrifuge manufacturing ramp-up and its impact on operational throughput, (2) updates on new contract wins and expansion of the enrichment backlog, and (3) progress in the advanced reactor and HALEU segments, including the pace of commercial fuel deliveries. We will also closely monitor the integration of Westerman and any further supply chain developments.

Centrus Energy currently trades at $87.62, down from $92.65 just before the earnings. Is there an opportunity in the stock? The answer lies in our full research report (it’s free).

Stocks that trumped tariffs

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.